Companies

Silo Pharma, Inc.

SILO · CIK 0001514183 · operating

$0.35-3.33%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap$4.75M
P/E
Fwd P/E-0.51
PEG
P/S65.87
P/B0.74
EV/EBITDA0.21
EV/Rev-15.49

Profitability

Gross Margin91.90%
Op. Margin-6526.44%
Net Margin-6092.59%
ROE-87.26%
ROA-59.27%
FCF Margin-5317.35%

Financial Health

Current Ratio4.29
Debt/Equity0.47
Free Cash Flow-$3.83M
Div. Yield

Growth & Other

Revenue Growth0.00%
EPS Growth
Beta0.61
52W High$1.447
52W Low$0.221

About Silo Pharma, Inc.

Silo Pharma, Inc. (SILO) is a pharmaceutical preparations company incorporated in NV, listed on the Nasdaq. With a market capitalization of $5 million, Silo Pharma, Inc. is a micro-cap company. The stock currently trades at $0.35, down 3.33% today, with a 52-week range of $0.22–$1.45.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-1.19$-1.19
2023
2022
2021$0.04$0.04
2020
2019
2018$-0.02$-0.02
2013
2012
2011

Annual Reports (10-K) · 14 filings

Report DateFiledAccession Number
2024-12-312025-03-280001013762-25-004139SEC ↗
2023-12-312024-03-250001213900-24-025615SEC ↗
2022-12-312023-03-240001213900-23-022813SEC ↗
2021-12-312022-03-280001213900-22-015521SEC ↗
2020-12-312021-03-290001213900-21-018270SEC ↗
2019-12-312020-03-200001213900-20-007000SEC ↗
2018-12-312019-04-040001213900-19-005789SEC ↗
2017-12-312018-04-020001213900-18-003903SEC ↗
2016-12-312017-03-310001213900-17-003182SEC ↗
2015-12-312016-06-140001213900-16-014221SEC ↗
2014-12-312015-03-310001213900-15-002298SEC ↗
2013-12-312014-03-310001213900-14-002019SEC ↗
2012-12-312013-03-050001213900-13-000946SEC ↗
2011-12-312012-01-260001213900-12-000322SEC ↗